TELCON RF PHARMACEUTICAL. Inc. (200230.KQ)
KRW 598.0
(0.0%)
KRW 598.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 36.3 Billion | 27.82 Billion | 37.84 Billion | 33.14 Billion | 52.47 Billion | 57.7 Billion |
| Cost of Revenue | 26.79 Billion | 25.21 Billion | 31.78 Billion | 28.82 Billion | 40.51 Billion | 51.45 Billion |
| Gross Profit | 9.5 Billion | 2.61 Billion | 6.05 Billion | 4.31 Billion | 11.96 Billion | 6.25 Billion |
| Operating Expenses | 5.46 Billion | 6.67 Billion | 10.61 Billion | 6.4 Billion | 8.89 Billion | 15.63 Billion |
| Selling, General and Administrative Expenses | 4.73 Billion | 5.4 Billion | 8.81 Billion | 4.53 Billion | 7.21 Billion | 11.59 Billion |
| Research and Development Expenses | 733.17 Million | 1.2 Billion | 1.63 Billion | 1.81 Billion | 1.62 Billion | 3.8 Billion |
| Other Expenses | - | -68.02 Million | -168.29 Million | -53.62 Million | -46.04 Million | -240.55 Million |
| Cost and Expenses | 32.26 Billion | 31.89 Billion | 42.4 Billion | 35.23 Billion | 49.4 Billion | 67.09 Billion |
| Operating Income | 4.03 Billion | -4.06 Billion | -4.56 Billion | -2.08 Billion | 3.07 Billion | -9.38 Billion |
| Interest Expense | 603.57 Million | 1.06 Billion | 7.7 Billion | 2.84 Billion | 1.83 Billion | 5.12 Billion |
| Income Tax Expense | -1.97 Billion | -32.8 Million | -108.79 Million | 18.94 Million | 332.2 Thousand | 1.41 Million |
| Earnings before Tax | 11.96 Billion | -37.3 Billion | -9.61 Billion | -37.97 Billion | -39.68 Billion | -15.17 Billion |
| Net Income | 13.9 Billion | -42.08 Billion | -23.09 Billion | -40.89 Billion | -52.64 Billion | -13.75 Billion |
| Earnings Per Share Basic | 124.00 | -396.72 | -262.93 | -477.80 | -635.43 | -178.51 |
| Earnings Per Share Diluted | 92.99 | -396.72 | -262.93 | -477.80 | -635.43 | -178.51 |
| Weighted Average Shares Outstanding | 112.14 Million | 106.08 Million | 87.84 Million | 85.58 Million | 82.85 Million | 77.05 Million |
| Weighted Average Shares Outstanding (Diluted) | 149.54 Million | 106.08 Million | 87.84 Million | 85.58 Million | 82.85 Million | 77.05 Million |
| Gross Margin | 0.26 | 0.09 | 0.16 | 0.13 | 0.23 | 0.11 |
| EBIT Margin | 0.14 | 0.01 | -0.01 | 0.07 | 0.14 | -0.09 |
| Profit Margin | 0.38 | -1.51 | -0.61 | -1.23 | -1.00 | -0.24 |
| EBITDA | 5.2 Billion | -36.77 Billion | -363.07 Million | -30.72 Billion | -33.41 Billion | -5.93 Billion |
| Earnings Before Tax Margin | 0.11 | -0.15 | -0.12 | -0.06 | 0.06 | -0.16 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 8.82 Billion | 8.03 Billion | 12.92 Billion | 36.3 Billion | 8.84 Billion | 7.37 Billion |
| Cost of Revenue | 7.53 Billion | 7.39 Billion | 8.83 Billion | 29.73 Billion | 7.53 Billion | 6.76 Billion |
| Gross Profit | 1.29 Billion | 645.55 Million | 4.08 Billion | 6.57 Billion | 1.31 Billion | 615.37 Million |
| Operating Expenses | 2.29 Billion | 1.61 Billion | 1.59 Billion | 5.6 Billion | 1.5 Billion | 1.12 Billion |
| Selling, General and Administrative Expenses | 2.13 Billion | 1.38 Billion | 1.42 Billion | - | 1.29 Billion | 934.49 Million |
| Research and Development Expenses | 150.82 Million | 217.4 Million | 142.85 Million | - | 193.88 Million | 181.83 Million |
| Other Expenses | -11.72 Million | -8.14 Million | -26.62 Million | -59.76 Million | -11.11 Million | -9.27 Million |
| Cost and Expenses | 9.83 Billion | 9 Billion | 10.42 Billion | 35.34 Billion | 9.03 Billion | 7.88 Billion |
| Operating Income | -1 Billion | -965.19 Million | 2.49 Billion | 965.31 Million | -192.6 Million | -510.22 Million |
| Interest Expense | 788.12 Million | 328.83 Million | 142.61 Million | 603.57 Million | 145.25 Million | 146.66 Million |
| Income Tax Expense | 5.86 Billion | -347.61 Million | 382.09 Million | -1.93 Billion | 923.62 Million | -56.52 Million |
| Earnings before Tax | -3.99 Billion | -7.62 Billion | 4.45 Billion | 11.96 Billion | -9.19 Billion | -27.37 Billion |
| Net Income | -9.86 Billion | -7.27 Billion | 4.07 Billion | 13.9 Billion | -10.11 Billion | -27.41 Billion |
| Earnings Per Share Basic | -84.53 | -62.72 | 36.10 | - | -90.45 | -246.78 |
| Earnings Per Share Diluted | -84.53 | -62.72 | 14.22 | - | -90.45 | -246.78 |
| Weighted Average Shares Outstanding | 116.71 Million | 115.99 Million | 112.84 Million | 111.79 Million | 111.88 Million | 111.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 116.71 Million | 115.99 Million | 386.57 Million | 149.54 Million | 111.88 Million | 111.1 Million |
| Gross Margin | 0.15 | 0.08 | 0.32 | 0.18 | 0.15 | 0.08 |
| EBIT Margin | 0.01 | 0.02 | 0.28 | - | 0.10 | 0.07 |
| Profit Margin | -1.12 | -0.91 | 0.32 | 0.38 | -1.14 | -3.72 |
| EBITDA | 63.86 Million | 131.27 Million | 3.6 Billion | - | 880.88 Million | 521.01 Million |
| Earnings Before Tax Margin | -0.11 | -0.12 | 0.19 | 0.03 | -0.02 | -0.07 |
002204
SCV
BCN
003780
STEL
6832